Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: OldBoar who wrote (1938)	5/12/2016 1:43:18 AM
From: mokelumne river	of 2026

>It would appear that Denner has an ability, (a) motive, and (an) opportunity to make (a) huge move with APRI...Does anyone agree? < Yes, I agree. What does Apricus need? 1. More cash for operating costs to make it through the FDA decision on Vitaros approval. (This assumes that Pascoe can't come up with enough cash by licensing some or all of RayVa or through royalty payments from EU sales of Vitaros...and I assume that.) 2. A higher share price (over a buck). If Apricus can score the cash then one can make a reasonable argument that the share price issue will/could be resolved. That is not a certainty, of course. What huge move can Denner make? Denner can't magically increase the share price, but he can come up with the cash for say steeply discounted shares or future royalties or something like that. OK, that isn't exactly brilliant but that is what we need, cash. Will Denner do something else...probably. James

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next